Laboratory of Analytical, Bioanalytical Sciences and Miniaturization, Chemistry, Biology and Innovation (CBI) UMR 8231, ESPCI Paris PSL, CNRS, PSL Research University, Paris, France.
"Pathophysiology & Pharmacotoxicology of the Human Placenta, pre & postnatal Microbiota", UMR-S 1139, Université Paris Cité, INSERM, Paris, France.
J Pharm Biomed Anal. 2025 Jan 1;252:116525. doi: 10.1016/j.jpba.2024.116525. Epub 2024 Oct 15.
Human chorionic gonadotropin (hCG) is a dimeric, highly glycosylated hormone with a total of 4 N- and 4 O-glycosylation sites in its two subunits, hCGα and hCGβ. Recently, we developed a novel nano liquid chromatography coupled to high resolution mass spectrometry (nanoLC-HRMS) method for the analysis and thus the detection of the intact glycoforms of hCG. Here, a sorbent functionalized with the Jacalin lectin was evaluated in solid-phase extraction (SPE) for its potential to fractionate the hCG glycoforms prior to their nanoLC-HRMS analysis at the intact level, which may facilitate the detection of low-abundance glycoforms and may lead to a more detailed characterization of the hormone glycosylation. A commercial sorbent based on Jacalin immobilized on Sepharose and having a lectin density of 4.5 mg per ml of gel was selected to carry out SPE and its capacity was estimated to be of some tens of μg of hCG per ml of lectin sorbent. Next, the SPE protocol was modified to improve the extraction recoveries. Especially, it was noticed that an extensive pre-conditioning procedure prior to the first use of a cartridge was necessary to remove the residual non-grafted lectins. Indeed, if non-grafted lectins are not eliminated, they may bind a part of hCG glycoforms preventing their retention by the sorbent, leading to low extraction recoveries (around 10 %). With the extensive pre-conditioning procedure, the average extraction recoveries for both hCGα and hCGβ glycoforms were about 50 %, with either recombinant or urinary hCG. Qualitatively, the fractionation of hCG glycoforms between the washing and elution fractions was achieved with the urinary hCG sample by determining the number of glycoforms detected in each fraction. It appears that 12 hCGα glycoforms have a low affinity (detected only in the washing fraction), 1 a low-medium affinity (detected in washing and elution 1 fractions), 16 a medium affinity (detected in washing, elution 1 and 2 fractions), and 12 a high affinity (detected only in elution 1 and 2 fractions). For the hCGβ glycoforms, similarly, 3 have a low affinity and 12 a low-medium affinity. Additionally, the 3 hCGβ glycoforms were detected better. A different behavior was observed with the recombinant hCG sample, which indicates glycosylation differences between the two hCG samples. This shows the potential of lectin-based affinity fractionation before nanoLC-HRMS analysis to better characterize the glycosylation state of hCG at the intact level.
人绒毛膜促性腺激素(hCG)是一种二聚体、高度糖基化的激素,其两个亚基 hCGα 和 hCGβ 共有 4 个 N-和 4 个 O-糖基化位点。最近,我们开发了一种新型的纳升液相色谱-高分辨质谱联用(nanoLC-HRMS)方法,用于分析和检测 hCG 的完整糖型。在这里,评估了一种用 Jacalin 凝集素功能化的固定相用于固相萃取(SPE),以在完整水平上分析 hCG 糖型,这可能有助于检测低丰度糖型,并可能导致对激素糖基化的更详细表征。选择了一种基于 Jacalin 的商业固定相,该固定相固定在琼脂糖上,其凝集素密度为每毫升凝胶 4.5mg,用于 SPE,其容量估计为每毫升凝集素固定相几十微克 hCG。接下来,修改了 SPE 方案以提高提取回收率。特别是,注意到在第一次使用试剂盒之前需要进行广泛的预处理步骤,以去除残留的未接枝凝集素。事实上,如果不消除未接枝的凝集素,它们可能会结合一部分 hCG 糖型,从而阻止它们被固定相保留,导致提取回收率低(约 10%)。通过广泛的预处理程序,无论是重组 hCG 还是尿 hCG,hCGα 和 hCGβ 糖型的平均提取回收率约为 50%。通过确定每个馏分中检测到的糖型数量,实现了尿 hCG 样品中 hCG 糖型的分级分离。似乎有 12 种 hCGα 糖型具有低亲和力(仅在洗涤馏分中检测到),1 种具有低-中亲和力(在洗涤和洗脱 1 馏分中检测到),16 种具有中等亲和力(在洗涤、洗脱 1 和 2 馏分中检测到),和 12 种具有高亲和力(仅在洗脱 1 和 2 馏分中检测到)。对于 hCGβ 糖型,同样有 3 种具有低亲和力和 12 种具有低-中亲和力。此外,检测到的 3 种 hCGβ 糖型更好。重组 hCG 样品的行为则不同,这表明两种 hCG 样品的糖基化差异。这表明在 nanoLC-HRMS 分析之前使用基于凝集素的亲和分级分离来更好地表征 hCG 的完整糖基化状态的潜力。